Novel insights into the mechanism of action of lenalidomide. - Wikidata - awgldk - TriplyDB

Novel insights into the mechanism of action of lenalidomide.

Novel insights into the mechanism of action of lenalidomide.

http://www.wikidata.org/entity/Q34373253

about

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Trial Watch-Immunostimulation with cytokines in cancer therapy Trial Watch: Proteasomal inhibitors for anticancer therapy Novel immune checkpoint blocker approved for the treatment of advanced melanoma Classification of current anticancer immunotherapies Trial watch: Naked and vectored DNA-based anticancer vaccines Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

P2860

Q26996518-6003F4B3-105F-4C8C-A49E-B759C48D6D75 Q27004011-316E2D25-E077-4231-A237-1426A4C933CA Q28078725-F66BDD83-F4F8-458C-BDE1-A4413C3682F5 Q28082910-928D247C-D2FD-4C24-9D6C-AE7C9FB28F72 Q34936394-B3F1155D-4ADE-4B6C-AB41-A6D8EB1FB9C6 Q35149637-4529E951-D1F6-47E4-90CA-1F7B40F51489 Q35798986-F2E1910D-6497-473E-923C-64D55A818FC2 Q37079141-9EFC6E5D-3E5D-4621-9A73-2E0A6DEBB873 Q42558833-F26A4A8B-14AC-4F5F-AB6B-32ED74D0E0D1 Q42702234-B83F33AD-D06B-402D-9369-E96D9018C224

P2860

Novel insights into the mechanism of action of lenalidomide.

http://www.wikidata.org/entity/Q34373253

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel insights into the mechanism of action of lenalidomide.

@ast

Novel insights into the mechanism of action of lenalidomide.

@en

Novel insights into the mechanism of action of lenalidomide.

@nl

type

label

Novel insights into the mechanism of action of lenalidomide.

@ast

Novel insights into the mechanism of action of lenalidomide.

@en

Novel insights into the mechanism of action of lenalidomide.

@nl

prefLabel

Novel insights into the mechanism of action of lenalidomide.

@ast

Novel insights into the mechanism of action of lenalidomide.

@en

Novel insights into the mechanism of action of lenalidomide.

@nl

P1433

Q34373253-EB800155-5D84-421A-8EE8-060C281C3D02

P1476

Q34373253-7FF066A8-22FA-4A34-8280-0DC0615962BB

P2860

Q34373253-03DB3597-8BCD-46FB-9B41-1C27E75D0132

Q34373253-0CEB9B8B-9F75-4D02-98A2-C7E44E99A982

Q34373253-1D82A4C8-2C67-4A16-B258-C6A20A99415B

Q34373253-323FC16C-895D-44D5-A53F-C5D30D59206B

Q34373253-33410845-7320-41BA-A842-A02B9BB6BB06

Q34373253-3EE3B597-0BB2-423D-B3D0-EDC02D94E03D

Q34373253-41423C0A-25DF-40ED-8361-40D787E26526

Q34373253-4193563D-08D2-455E-AE4B-688A89EF830F

Q34373253-47B3D002-49B4-43EC-8CF7-12E0C531A743

Q34373253-4A5CC7E3-488C-4E3A-BB4A-9BFA15E0661A

P304

Q34373253-E7DDB950-1AFD-4024-B7F0-FB8F15A972B8

P31

Q34373253-5F31F060-E2B2-4EC2-939B-3095DDFF6B2D

Q34373253-75693b5f-1caa-4851-8756-7b8ab5d48fe6

P356

Q34373253-A3AD7DA8-C94F-4C00-B010-97052130B528

P478

Q34373253-3916E7F0-0F09-4CC7-8627-A55309A6FCF9

P50

Q34373253-2F9B5209-163E-43C9-B400-D5E8B833A87C

Q34373253-A44E9BD6-0888-406D-8C62-9FA57BD39BBF

P577

Q34373253-BBE0D37C-DB70-4394-B19F-DE171F5AFF7D

P5875

Q34373253-26AC1C1A-CA9B-4D13-B79D-8A588E977632

P698

Q34373253-E58B5FF8-1E1E-4247-B7D3-26234AB6A2BA

P932

Q34373253-D49800C0-2484-4FAB-B1C4-56B149779698

P356

P1433

P1476

Novel insights into the mechanism of action of lenalidomide.

@en

P2860

Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma

Identification of a primary target of thalidomide teratogenicity

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells

Efficacy of lenalidomide in myelodysplastic syndromes.

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

P304

e28386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.28386

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Galluzzi

Michaela Semeraro

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267736039

http://www.w3.org/2001/XMLSchema#string

P698

25340011

http://www.w3.org/2001/XMLSchema#string

P932

4203586

http://www.w3.org/2001/XMLSchema#string